Synthomer
Synthomer plc (LSE: SYNT), formerly known as Yule Catto & Co, is a British-based chemicals business. It is a constituent of the FTSE 250 Index.
Type | Public |
---|---|
LSE: SYNT | |
Industry | Chemicals |
Founded | 1863 |
Headquarters | London, England |
Key people | Neil Johnson (Chairman) Calum MacLean (CEO) |
Revenue | £1,459.1 million (2019)[1] |
£125.8 million (2019)[1] | |
£85.6 million (2019)[1] | |
Number of employees | 2,900 (2019)[2] |
Website | www.synthomer.com |
History
The company traces its roots back to 1863, when Andrew Yule founded a trading house known as Andrew Yule & Co. in Calcutta.[3] At the same time Andrew's brother, George Yule, set up George Yule & Co. in London, which acted as British agency arm of Andrew Yule & Co.[4]
When in 1919 Andrew Yule & Co. and George Yule & Co. were sold to the US banking group J.P. Morgan & Co. and its British merchant banking affiliate Morgan Grenfell & Co., both were turned from a partnership into a private limited company.[5] That same year Thomas Catto (1879–1959) was sent to India to take over the management of the firm from Sir David Yule (1858–1928), a nephew of Andrew Yule.[6] David Yule continued to hold the title of Chairman but had no active part in the operations of the business.[6]
In 1920 Thomas Catto and David Yule changed the name of the British purchasing arm of Andrew Yule & Co., George Yule and Company, to Yule, Catto & Company Ltd.[7] Due to increased taxation, the devaluation of the Indian rupee and the abolition of the managing agency system, Yule, Catto & Co decided in 1969 to sell its shareholding in Andrew Yule & Co. to the Indian government.[8]
With the acquisition of Revertex Chemicals in 1980,[7] Thomas Catto's son, Stephen (1923–2001) started to turn Yule Catto & Co. into an international speciality chemicals and building products manufacturer.[9] Since 2007 the group has been transformed from a diversified chemical business to a focussed speciality polymer business. In 2012 the company changed its name to Synthomer on the basis that the majority of its business already traded under that name.[10]
In July 2019, Synthomer announced that it was going to buy OMNOVA Solutions for an enterprise value of $824 million in a bid to strengthen its global position as heard from Reuters.[11] The deal was completed on April 2, 2020.[12]
Operations
The company has three activities: polymer chemicals, pharma chemicals and impact chemicals.[3]
References
- "Annual Results 2019" (PDF). Synthomer. Retrieved 5 March 2020.
- "Our business". Retrieved 20 March 2019.
- "Yule Catto - Company Structure Information from ICIS". icis.com. Retrieved 3 April 2015.
- Yule, Catto & Co AIM 25
- Jones, p.96
- Jones, p.325
- Jones, p. 297
- Obituary: Lord Catto Daily Telegraph, 6 September 2001
- Interim Management Statement of Yule Catto & Co Plc for the period 1 July to 8 November 2012
- https://www.reuters.com/article/us-omnova-solutions-m-a-synthomer-plc-idUSKCN1TY0PK
- https://www.rubbernews.com/acquisition/synthomer-completes-acquisition-omnova
Sources
- Jones, Geoffrey (2007). Merchants to Multinationals. Oxford University Press. ISBN 978-0-19-829450-4.